Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostanoid release after lung transplantation

P O Kimblad1, K Gréen, T Sjöberg

  • 1Departmentof Cardiothoracic Surgery, University Hospital, Lund, Sweden.

The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|October 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dynamic EBV gene loads in renal, hepatic, and cardiothoracic transplant recipients as determined by real-time PCR light cycler.

Transplant infectious disease : an official journal of the Transplantation Society·2005
Same author

Health literacy and patient knowledge in a Southern US HIV clinic.

International journal of STD & AIDS·2004
Same author

Effects of instructions on physical capacities outcome in a workers' compensation setting.

Pain medicine (Malden, Mass.)·2004
Same author

Improved glucose homeostasis in mice overexpressing human UCP3: a role for AMP-kinase?

International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity·2004
Same author

Association of human leukocyte antigen with outcomes of infectious diseases: the streptococcal experience.

Scandinavian journal of infectious diseases·2003
Same author

Changes in EBV gene load in renal transplant recipients.

Transplantation proceedings·2003

Lung transplantation significantly increases thromboxane A2 production, a potent vasoconstrictor. However, this is counteracted by a substantial increase in prostacyclin, a vasodilator, potentially mitigating adverse effects.

Area of Science:

  • Cardiovascular Science
  • Transplantation Biology
  • Pulmonary Medicine

Background:

  • Pulmonary vascular resistance often increases post-lung transplantation.
  • Thromboxane A2 (TXA2) is a key pulmonary vasoconstrictor.
  • Prostacyclin (PGI2) counteracts TXA2-induced vasoconstriction.

Purpose of the Study:

  • To investigate the impact of lung transplantation on TXA2 and PGI2 biosynthesis.
  • To understand the role of these eicosanoids in post-transplant pulmonary hemodynamics.

Main Methods:

  • Donor pigs underwent lung transplantation or sham operations.
  • Urine levels of TXA2 metabolite (2,3-dinor-TXB2) and PGI2 metabolite (2,3-dinor-6-keto-PGF1α) were measured.
  • Gas chromatography-mass spectrometry was used for metabolite quantification.

Related Experiment Videos

Main Results:

  • TXA2 production peaked at fivefold above basal levels 1-4 hours post-transplant (vs. twofold in sham).
  • Prostacyclin production increased significantly, reaching 15-fold by 4-8 hours and 18-fold by 20-24 hours post-transplant (vs. twofold and sevenfold in sham, respectively).
  • No correlation was found between eicosanoid levels and pulmonary vascular resistance or pressure.

Conclusions:

  • Lung transplantation leads to a fivefold increase in TXA2 production.
  • A concomitant 15-fold increase in prostacyclin synthesis occurs post-transplantation.
  • This enhanced prostacyclin production may counterbalance the vasoconstrictive effects of increased TXA2.